For Corporate Purchasing Managers, Technical Directors & Operations Leaders seeking high‑purity, low‑cost MC1R/MC4R ligands that meet FDA, GMP and ISO standards.
Get Free Sample in 24 hIn 2025, 37 % of R&D budgets were wasted on ligands that failed potency or stability tests. The root causes are rarely technical; they are supply‑chain and compliance problems that hit the bottom line.
Imagine the lost opportunity cost when a promising MC4R antagonist stalls at the assay stage for weeks because the ligand arrives late or fails purity specs. The data below illustrates the impact:
| Issue | Typical Cost Impact | Potential Savings with Global Tech |
|---|---|---|
| Over‑priced raw material | $12,000 per 10 g batch | ‑$7,200 (40 % lower) |
| Re‑synthesis due to impurity | $5,400 per batch | ‑$3,240 |
| Delayed clinical milestone | $30,000‑$50,000 | ‑$20,000 (average) |
| Parameter | MC1R Ligand (Compound A) | MC4R Ligand (Compound B) |
|---|---|---|
| Molecular Weight (g/mol) | 432.5 | 458.6 |
| Purity (HPLC) | ≥99.5 % | ≥99.5 % |
| Assay (LC‑MS) | 99.8 % ±0.1 % | 99.7 % ±0.1 % |
| Stability (25 °C/60 % RH) | 24 months | 24 months |
| Solubility | DMSO 10 mg/mL; water <0.5 mg/mL | DMSO 12 mg/mL; water <0.6 mg/mL |
| Packaging | Amber vial, 100 mg – 5 kg | Amber vial, 100 mg – 5 kg |
| Certificates | GMP, FDA‑DMF, ISO 9001, RoHS | GMP, FDA‑DMF, ISO 9001, RoHS |
Scenario 1 – Obesity & Metabolic Disorder Screening
A US‑based biotech used our MC4R selective antagonist (Compound B) to validate a high‑throughput assay. Results: IC₅₀ = 3.2 nM with ≤5 % CV. The project moved from discovery to pre‑clinical IND filing in 12 weeks, saving $45,000 in re‑synthesis costs.
MCHR1-MCHR2-ligand-for-drug-discovery-supplier Melanocortin-peptide-research-supplier-ligand Primate-specific-melanocortin-peptide-receptor-ligand MCHR1-agonist-analog-supplier-receptor-research
Scenario 2 – Dermatology Pigmentation Research
A European CRO required a MC1R agonist with >99 % enantiomeric purity for a skin‑cell assay. Our custom‑synthesized ligand delivered on day 8, enabling the client to meet a regulatory deadline 2 weeks early.
Scenario 3 – Academic Collaboration (MIT)
MIT’s pharmacology department partnered with Global Technology for isotopically labeled MC1R ligand (^13C). The label was incorporated with 98 % isotopic enrichment, supporting mass‑spec quantitation in vivo. Publication in Nature Chemical Biology cited our product as a key enabler.
The MOQ is 100 mg for research‑grade material. For bulk GMP‑grade, the MOQ starts at 1 kg. Both options include a full certificate of analysis.
Yes. Our OEM/ODM team can incorporate up to 98 % isotopic enrichment. Lead time is 14‑21 days depending on scale.
All batches are manufactured in GMP‑certified facilities, accompanied by a DMF, FDA‑compliant Certificate of Analysis, and a full audit trail. We also provide a “Regulatory Support Package” on request.

We offer DHL Express (2‑3 days) and FedEx International Priority (3‑4 days). All shipments are in temperature‑controlled packaging with real‑time tracking.
Absolutely. If the batch analysis shows purity below 99.5 %, we will replace the material at no additional cost or issue a full refund.
Complete the short form on our Free Sample Request page. We ship the sample within 24 hours of approval.
Limited‑time offer: **Free 100 mg sample + 10 % discount on the first 5 kg order**. Stock is limited to 500 g per month to guarantee consistent quality.
“Fast, reliable, and cost‑effective. The MC1R ligand arrived in 8 days and passed our potency assay on the first try.”
- James L., Procurement Manager, Pfizer
“The OEM service saved us 3 months of development time. Custom isotopic labeling was perfect for our pharmacokinetic study.”
- Dr. Maya K., Lead Chemist, Novartis
“Their compliance package made the IND filing painless. No surprises during FDA review.”
- Samuel R., Regulatory Affairs, Roche
Trusted by Industry Leaders Worldwide
Certificates & Compliance – CE, FDA, ISO 9001, GMP, DMF, RoHS, HACCP/GMP, CB, VDE, SAA, IPPC. All documents are downloadable from our secure portal.
See full compliance package →